Company insight
Presenting innovative biocompatible solutions
BioInteractions, a leading global biomaterial technology company, has chosen one of the world’s leading platforms for state-of-the-art medical technologies, COMPAMED, as the venue to showcase its full suite of innovative biocompatible solutions. On show will be the organisation’s new groundbreaking coating technology for medical devices TridAnt, alongside the widely proven Astute and Assist solutions.
T
ridAnt is a non-leaching, highly effective, safe and durable antimicrobial coating for even the most sensitive medical devices and implants, helping to save lives and time needed in medical treatment. The TridAnt technology is based on three decades of dedicated research and trials, the result of which is a fully medical device regulation-compliant technology that has been independently tested to international standards (ISO, EN, PAS). It is the first known medical device technology to kill enveloped as well as non-enveloped viruses and gram-positive as well as gram-negative bacteria and prevents the formation of biofilms for long periods of time of up to 365 days (as well as safe enough to protect skin for up to 48 hours) without any noticeable reduction in efficacy. According to the National Institute for Health and Care Excellence (NICE), an estimated 300,000 patients a year in England acquire a healthcare associated infection (HCAI) after spending time in NHS care.
“HCAIs are a significant burden on our healthcare systems both in the UK and across the world,” explains Arjun Luthra, BioInteractions’ commercial director. “At BioInteractions, we understand the broad impact they have, and have developed a technology platform in TridAnt to tackle these from a preventative standpoint. Antibiotics, vaccines and other drugs help to treat bacterial infections, but they are limited in their overall impact. What is needed in the future is an antimicrobial solution that works alongside other measures to prevent the infection from taking hold long-term.” Overall, TridAnt significantly reduces the infection risk associated with medical
formation on devices in a variety of ways with no rejection over long periods of time and under stressful conditions. This enhances the hemocompatibility and the durability of the device, especially when in contact with blood. The applications for Astute incorporate a wide range of medical devices including catheters, dialysis membranes, coronary stents, neurological and diagnostic devices.
The TridAnt technology developed by BioInteractions is designed for the most sensitive medical devices.
procedures and actively reduces the contamination of pathogens within a patient. It is an important addition to the arsenal available to medical professionals in the fight against life- threatening infections and secondary complications when operating on patients. This enhances the well-being of a patient and allows more effective and efficient procedures for professionals.
The Astute Antithrombogenic Coating has obtained clinical recognition for its safe and successful use on blood contacting medical devices. The active anti-thrombogenic components halt the blood clotting cascade mechanism. This is combined with passive non-thrombogenic elements to prevent deposition and adhesion on the device surface. The multi-action technology confronts clot
Medical Device Developments /
www.nsmedicaldevices.com
Assist Hydrophilic Coating has delivered a high-performance lubricious surface for long-term applications without particulate formation or delamination of the coating on devices approved both in the US and Europe. The coating enhances biocompatibility of the surfaces while enabling the surface to significantly decrease the frictional resistance. This radically reduces tissue damage and improves comfort when delivering or removing devices from the patient. Assist is well suited to a wide range of medical applications, including highly movable and stressful components such as large balloon catheters and joint devices, tissue contacting devices such as urinary catheters and endotracheal tubes, as well as blood contacting devices, such as PTA catheters. The coating can be applied to various substrates and is scientifically formulated as a fast heat-curing and UV-curing process.
BioInteractions’ groundbreaking technology innovations will be on show at this year’s COMPAMED event in Messe Dusseldorf, Germany from the 14–17 November. Showcasing its innovations on Hall 8B, stand N30, the company will have experts on hand to discuss the solutions. ●
www.biointeractions.com 119
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170
